<?xml version="1.0" encoding="UTF-8"?>
<ref id="B30-pharmaceutics-13-00230">
 <label>30.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Fr√∂hlich</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Ndreshkjana</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Muenzner</surname>
    <given-names>J.K.</given-names>
   </name>
   <name>
    <surname>Reiter</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Hofmeister</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Mederer</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Fatfat</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>El-Baba</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Gali-Muhtasib</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Schneider-Stock</surname>
    <given-names>R.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Synthesis of Novel Hybrids of Thymoquinone and Artemisinin with High Activity and Selectivity Against Colon Cancer</article-title>
  <source>ChemMedChem</source>
  <year>2017</year>
  <volume>12</volume>
  <fpage>226</fpage>
  <lpage>234</lpage>
  <pub-id pub-id-type="doi">10.1002/cmdc.201600594</pub-id>
  <pub-id pub-id-type="pmid">27973725</pub-id>
 </element-citation>
</ref>
